|
Volumn 41, Issue 9, 2008, Pages 779-784
|
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
a a b c c d e f g a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORTEZOMIB;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
FLUDARABINE;
MELPHALAN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
THALIDOMIDE;
THYMOCYTE ANTIBODY;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BONE METASTASIS;
CANCER INCIDENCE;
CANCER LOCALIZATION;
CANCER RELAPSE;
CHROMOSOME 13;
CHROMOSOME DELETION;
CONTROLLED STUDY;
DONOR LYMPHOCYTE INFUSION;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MULTIPLE MYELOMA;
NONMYELOABLATIVE STEM CELL TRANSPLANTATION;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
WHOLE BODY RADIATION;
ADULT;
AGED;
CHROMOSOME DELETION;
CHROMOSOMES, HUMAN, PAIR 13;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LIVING DONORS;
LYMPHOCYTE TRANSFUSION;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
RECURRENCE;
STEM CELL TRANSPLANTATION;
SURVIVAL RATE;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 43849091411
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/sj.bmt.1705982 Document Type: Article |
Times cited : (45)
|
References (18)
|